Bristol Myers Squibb's $400 Billion Windfall: A Deal Too Good to Be True?
The pharmaceutical industry is abuzz with rumors of a massive merger between Bristol Myers Squibb and AstraZeneca, which could create the world's largest drugmaker by revenue.
This potential transaction has sent Bristol Myers' stock soaring, as investors hope that a tie up would shield the company against looming patent cliffs and provide global scale and complementary pipelines.